Free tool
Healthcare stocks
We cover 24 companies in the Healthcare sector. The median market value in the group is $38.56B. Across the group, the median move over the past trading day is +0.38%. 100% of the 23 with a 200-day average trade above it. Price change over the past year runs from +5.4% to +128.6% across the middle 80 percent of the group, with a median of +47.1%.
Other lists in this group
Table
24 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% | Oct 29, 2026 |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% | Nov 3, 2026 |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% | Nov 3, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% | Oct 21, 2026 |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $84.24B | Large cap | −5.91% | Oct 28, 2026 |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% | Oct 22, 2026 |
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +550.51% | Nov 5, 2026 |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% | Nov 5, 2026 |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% | Nov 5, 2026 |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% | Nov 5, 2026 |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% | Nov 3, 2026 |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +129.80% | Oct 29, 2026 |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% | Oct 29, 2026 |
| 22UA.DE | BioNTech SE | $28.28B | Large cap | +14.09% | Nov 3, 2026 |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% | Nov 3, 2026 |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% | Oct 20, 2026 |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% | Nov 5, 2026 |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% | Nov 5, 2026 |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% | Nov 4, 2026 |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% | Nov 2, 2026 |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% | Oct 29, 2026 |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% | Nov 3, 2026 |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% | Nov 9, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.